None
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Samples from our hospital, either from surgical resection or biopsy based on clinical decision-making, yielding residual tissue suitable for research, or from biological samples retained during previous diagnosis and treatment in our hospital; 2.Informed consent from the subjects has been obtained; 3.Complete intraoperative/postoperative pathological reports or biopsy pathological reports are available to confirm the tissue type; 4.The sample meets the laboratory quality control standards; 5.Clinical baseline information can be obtained for correlation analysis;
Exclusion criteria
Exclusion criteria: 1.The subject did not provide or withdrew informed consent, or the scope of sample authorization did not include the use in this study; 2.Significant quality issues arose during the specimen collection process, rendering the specimens unusable for imaging (such as severe damage, contamination, and drying and cracking of the samples); 3.The sample size is insufficient to complete the prescribed 3D imaging process (e.g., the specimen volume is less than the minimum acquisition threshold); 4.The subject has a comorbid serious infectious disease and there are unresolved biosafety hazards in sample processing, which cannot be safely addressed in compliant facilities; 5.The pathological diagnosis is unclear and the tissue type remains undetermined even after review; 6.Other situations that are not suitable for inclusion in this study (such as samples already being used in other research projects that cannot be shared, or legal/ethical restrictions);
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ; | — |
Countries
China
Contacts
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology